E-LIB Suche - Ergebnisse für: Wolden, Michael

1

Outcomes in GLP-1 RA-Experienced Patients Switching to Once..:

Lingvay, Ildiko ; Kirk, Andreas R. ; Lophaven, Søren..
Diabetes Therapy. 12 (2021) 3 - p. 879-896 , 2021

Link: https://doi.org/10.1007/..

2

Real-world clinical outcomes following treatment intensific..:

Desouza, Cyrus ; Kirk, Andreas R ; Mangla, Kamal K..
BMJ Open Diabetes Research & Care. 8 (2020) 2 - p. e001830 , 2020

Link: https://doi.org/10.1136/..

3

The Burden of Hypoglycemia in Patients With Insulin-Treated..:

Yue, Xiaomeng ; Wu, Jiuhong ; Ruan, Zhen...
Value in Health Regional Issues. 21 (2020) - p. 17-21 , 2020

Link: https://doi.org/10.1016/..

4

Cost-effectiveness of switching to insulin degludec from ot..:

Haldrup, Steffen ; Lapolla, Annunziata ; Gundgaard, Jens.
Journal of Medical Economics. 23 (2019) 3 - p. 271-279 , 2019

Link: https://doi.org/10.1080/..

5

Switching to Degludec From Other Basal Insulins Is Associat..:

Fadini, Gian Paolo ; Feher, Michael ; Hansen, Troels Krarup...
The Journal of Clinical Endocrinology & Metabolism. 104 (2019) 12 - p. 5977-5990 , 2019

Link: https://doi.org/10.1210/..

6

A comparative effectiveness study of degludec and insulin g..:

Tibaldi, Joseph ; Hadley‐Brown, Martin ; Liebl, Andreas...
Diabetes, Obesity and Metabolism. 21 (2019) 4 - p. 1001-1009 , 2019

Link: https://doi.org/10.1111/..

7

Diabetes management and daily functioning burden of non‐sev..:

Ohashi, Yasuo ; Wolden, Michael L ; Hyllested‐Winge, Jacob.
Journal of Diabetes Investigation. 8 (2017) 6 - p. 776-782 , 2017

Link: https://doi.org/10.1111/..

8

A European, multicentre, retrospective, non‐interventional ..:

Siegmund, Thorsten ; Tentolouris, Nikolaos ; Knudsen, Søren T....
Diabetes, Obesity and Metabolism. 20 (2017) 3 - p. 689-697 , 2017

Link: https://doi.org/10.1111/..

9

Self-reported hypoglycaemia in patients with type 2 diabete..:

Rauh, Simone P ; Rutters, Femke ; Thorsted, Brian L...
BMJ Open. 6 (2016) 9 - p. e012793 , 2016

Link: https://doi.org/10.1136/..

10

Liraglutide 3.0 mg Reduces Body Weight and Improves Health-..:

Liutkus, Joanne F. ; Fujioka, Ken ; Astrup, Arne...
Canadian Journal of Diabetes. 39 (2015) - p. S36 , 2015

Link: https://doi.org/10.1016/..

11

Delay in treatment intensification increases the risks of c..:

Paul, Sanjoy K ; Klein, Kerenaftali ; Thorsted, Brian L..
Cardiovascular Diabetology. 14 (2015) 1 - p. , 2015

Link: https://doi.org/10.1186/..

12

Increased Risk of Severe Hypoglycemic Events with Increasin..:

Sreenan, Seamus ; Andersen, Marc ; Thorsted, Brian Larsen..
Diabetes Therapy. 5 (2014) 2 - p. 447-458 , 2014

Link: https://doi.org/10.1007/..

13

Clinical Inertia in People With Type 2 Diabetes:

Khunti, Kamlesh ; Wolden, Michael L. ; Thorsted, Brian Larsen..
Diabetes Care. 36 (2013) 11 - p. 3411-3417 , 2013

Link: https://doi.org/10.2337/..

14

Non-severe nocturnal hypoglycemic events: experience and im..:

Brod, Meryl ; Pohlman, Betsy ; Wolden, Michael.
Quality of Life Research. 22 (2013) 5 - p. 997-1004 , 2013

Link: https://www.jstor.org/st..

15

Understanding the Economic Burden of Nonsevere Nocturnal Hy..:

Brod, Meryl ; Wolden, Michael ; Christensen, Torsten.
Value in Health. 16 (2013) 8 - p. 1140-1149 , 2013

Link: https://doi.org/10.1016/..